View clinical trials related to Gene Expression Profiling.
Filter by:The purpose of the study is to investigate the proportion of the cell-of-origin (COO) subtypes in relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) treated with BTK inhibitor or lenalidomide and its biosimilars.
To analyze the genome pattern in human gastric Intestinal Metaplasia Mucosa and duodenal Mucosa.
The investigators want to develop a gene expression profile for the prediction of immunotherapy response of patients with metastatic breast cancer presenting malignant pleural effusion.